Archive for June, 2008

Levitra and equipments stolen from medical office

Friday, June 27th, 2008

A thief struck a Delaware Avenue medical office building late last week and stole quantities of several drugs including ED drugs Levitra as reported by Buffalo police. A representative for the office at 1275 Delaware Avenue told police that sometime between 6 p.m. on Thursday and 1 p.m. on Friday, someone forced open a locked storage room and took multiple boxes of the drugs Cialis, Levitra and Viagra as well as the antibiotic Cipro and boxes of injection and syringe needles, according to the reports.

Police and office staff have a suspect in the case but no other details are available at the moment. Levitra is a FDA-approved oral prescription medication for the treatment of erectile dysfunction (ED) in men. It helps in increasing blood flow to the penis and may help men with ED get and keep an erection satisfactory for sexual activity. Levitra has been clinically shown to improve erectile function even in men who had other health factors, like diabetes or prostate surgery.

EVITRA VS VIAGRA: Owners Are Different

Friday, June 13th, 2008

The erectile dysfunction drug Levitra is manufactured by Bayer Corp. and distributed by GlaxoSmith Kline while Viagra is the product of the drug manufacturing company, Pfizer.

The deal between NFL and Levitra comes to an end

Monday, June 2nd, 2008

The three-year-old sponsorship deal between NFL and the marketers of erectile dysfunction drug Levitra will not be renewed after it expires in March, 2006. Brian McCarthy, an NFL spokesman, said the league chose to end the relationship because the ads of Levitra shifted from men’s health to a performance, lifestyle issue and the change in advertising strategy made the NFL uncomfortable about the partnership.

Some of the ads of erectile disfunction drug Levitra had been criticized for their racy content, along with other ads for erectile dysfunction, adding to the backlash against direct-to-consumer pharmaceutical advertising. Guidelines adopted by the drug companies last year say direct-to-consumer ads should be targeted to avoid audiences that are not appropriate for the message, a move widely viewed as limiting children’s exposure to them.